Pathology Watch
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Pathology Watch was a Salt Lake City digital pathology company founded in New York in 2017. It built an integrated, end-to-end digital pathology platform for dermatopathology, modernizing traditional lab processes with AI: cases were digitized so multiple physicians could review them in real time through dermatology medical-record systems, enabling faster turnaround, more accurate diagnoses and computer-aided diagnosis via deep learning. The company raised a $7 million Series A in 2020 and a $25 million Series B in 2021.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Pathology Watch is founded in New York as an integrated digital pathology service for dermatologists, later relocating to Utah.
- Funding rounds
The company completes a $7 million Series A in December 2020 and announces a $25 million Series B in November 2021 led by Ceros Capital Markets.
- Acquired by Sonic Healthcare
Australia's Sonic Healthcare acquires Pathology Watch for a reported $150 million to accelerate its transition to digital pathology and pathology AI; the founders and team join Sonic's U.S. and global operations.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.